DesiMiami Posted - 1 week ago

$SLN 👀

Prime88 Posted - 2 weeks ago

$SLN Stupid cheap here expect 20X run minimum $4 million market cap is a joke they have over $2.00 a share in net equity and will do 300 million in revenues this year with .25 a share in cash. Management just announced taking a large equity stake saying share price in now way reflects value of the company.

Stock_Titan Posted - 2 weeks ago

$SLN Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a) https://www.stocktitan.net/news/SLN/silence-therapeutics-announces-jama-publication-of-additional-phase-3ve8yi4fto6l.html

rodebo Posted - 03/27/24

$ICP.X $INJ.X $ARKM $FET.X $BCUT.X $SLN to the moon.

lecorb Posted - 1 month ago

@Tundra3 Get informed before you speak!!!!! European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm $TCBP and NuCana $NCNA, which lost 10% and 8.2% respectively. They were followed by pharmaceutical firms Silence Therapeutics $SLN and Mereo BioPharma Group $MREO, which fell 6.6% and 2.6% respectively. https://www.marketscreener.com/quote/stock/BBVA-69719/news/European-Equities-Traded-in-the-US-as-American-Depositary-Receipts-Nudge-Lower-in-Friday-Trading-46210642/

AnaChart Posted - 1 month ago

$SLN https://anachart.com/wp-content/uploads/ana_temp/1710439335_soc-img.jpg

AnaChart Posted - 1 month ago

$SLN https://anachart.com/wp-content/uploads/ana_temp/1710435721_soc-img.jpg

swindled_my_broker Posted - 1 month ago

$SLN WTF... this looks great.

Quantumup Posted - 1 month ago

BMO Capital $SLN "Weakness a Unique Opportunity to buy the dip;" Reiterated as Top Pick~$67/OP Despite the fact Zirlesiran data "met/beat" inv expys, SLN is down. BMO reits high conviction on 2 de-risked/differentiated programs=multi-billion$ comm opps; low valuation vs peers; '24 catalyst. $alny $ions $arwr

briefingcom Posted - 1 month ago

$SLN: Silence Therapeutics reports FY23 EPS of (38.9) pence compared to (41.9) pence in FY22, revenue increased 45% yr/yr to £25.38 mln

epsguid Posted - 1 month ago

$SLN reported a loss of $0.47, consensus was ($0.25) via @eWhispers #epsmiss http://eps.sh/d/sln

Stock_Titan Posted - 1 month ago

$SLN Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights https://www.stocktitan.net/news/SLN/silence-therapeutics-reports-full-year-2023-financial-results-and-gp6tzxau8f24.html

Stock_Titan Posted - 1 month ago

$SLN Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a) https://www.stocktitan.net/news/SLN/silence-therapeutics-announces-positive-topline-36-week-data-from-lnt5hz84m0c3.html

Stock_Titan Posted - 02/28/24

$SLN Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024 https://www.stocktitan.net/news/SLN/silence-therapeutics-to-report-fourth-quarter-and-full-year-2023-dc0sg8czxh50.html

briefingcom Posted - 2 months ago

$SLN: Silence Therapeutics announces that the initiation by AstraZeneca $AZN of a phase 1 clinical trial of the first product candidate under its siRNA collaboration, has triggered a $10.0 mln milestone payment to Silence https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240223080712SLN&utm_campaign=inplay&utm_medium=social&utm_source=twitter&utm_content=view_page

theflynews Posted - 2 months ago

Fly Intel: Pre-market Movers - $SLN - https://thefly.com/permalinks/entry.php/SLNid3869325

DonCorleone77 Posted - 2 months ago

$SLN $AZN Silence Therapeutics to receive $10M from AstraZeneca following trial initiation Silence Therapeutics (SLN) announced that the initiation by AstraZeneca (AZN) of a phase 1 clinical trial of the first product candidate under its siRNA collaboration, has triggered a $10M milestone payment to Silence. Silence and AstraZeneca initiated a multi-target collaboration in March 2020 focused on using Silence's proprietary mRNAi Gold platform to develop siRNA therapeutics for cardiovascular, renal, metabolic and respiratory diseases. Under the agreement, AstraZeneca will pay Silence an option fee of $10M for each selected target at the point of candidate nomination. The deal covers up to ten targets. For each target selected, Silence is eligible for up to $140M in development milestones and up to $250M in commercialization milestones as well as tiered royalties on net sales ranging from high single digit to low double digit.

TheTradeXchange Posted - 2 months ago

$SLN - Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial

Stock_Titan Posted - 2 months ago

$SLN Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial https://www.stocktitan.net/news/SLN/silence-therapeutics-achieves-10-million-milestone-payment-from-rag6wuav50ox.html

MaverikIT Posted - 2 months ago

@net0trader @Im_not_Mr_Lebowski @RonIsWrong @Wigglyick @Cash4freedom @IsabellaDC $SLN

Quantumup Posted - 2 months ago

BMO Capital: Three Key Reasons to Buy $SLN , Our New 1H24 Top Pick Heading into 2024, our 1H24 top picks included $FDMT (for 4D-150 PhII readout) and $ALNY (for HELIOS-B readout). Following the successful 4D-150 PhII readout, we now pick $SLN as our favorite name for 1H24, along with $ALNY. $SLN's lead program is a fully owned siRNA constituting one of the most advanced/competitive clinical agents in the emerging $20B+ Lp(a) space. Our high conviction in $SLN is based on the high PoS of the Lp(a) program whose data readouts and potential partnership in 2024 can drive significant upside. $AMGN $LLY

Stock_Titan Posted - 2 months ago

$SLN Silence Therapeutics Announces Oversubscribed $120 Million Private Placement https://www.stocktitan.net/news/SLN/silence-therapeutics-announces-oversubscribed-120-million-private-fpliggtna58p.html

ALPHATRADE22 Posted - 2 months ago

soared on our analyst's entry alert, securing a hefty 48% profit for our $CATX $SLN $POWL #discord_link_in_bio

RuthRussella Posted - 2 months ago

$CATX $PLTR $NMR $SLN I’ve made $147,883.65 with their alerts, Big thanks to this chat room.- Make as much as you want'''’'👓 https://stocks-gainer-market-community.profitablestocks.vip/

ALPHATRADE22 Posted - 2 months ago

The education provided at campus trading is top tier. Without them, I wouldn't have a portfolio worth almost 2 million.$NMR $CATX $SLN #discord_link_in_bio

NellRollings Posted - 2 months ago

$GOOG $NMR $CATX $SLN Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts.. Highly recommended! It's free joining''~!~''👓 best-stock-winning-tradesmarket.profitablestocks.vip/

NellRollings Posted - 2 months ago

$JL $NYXH $SLN $AGAE Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts.. Highly recommended! It's free joining''-;-''👓 best-stock-winning-tradesmarket.profitablestocks.vip/

MariaMoody2 Posted - 2 months ago

$SLN $CATX $NMR $KAMN Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts.. Highly recommended! It's free joining'.,'''👓 best-stock-winning-tradesmarket.profitablestocks.vip/

Nosh Posted - 01/31/24

$SLN 19.50 would have been a good entry here....will wait it out.

Quantumup Posted - 01/31/24

BMO Capital🏁initiated $SLN ("A Major Player in the Emerging $20B+ Lp(a) Space," w/ No Approved Tx's), at Outperform/$67 $amgn $lly $alny BMO says, $SLN's zerlasiran demonstrated up to 100% Lp(a) reduction in clinic, a target that is linked to cardiovascular risk. BMO~OP⬆️thesis,+: